Literature DB >> 31285227

Anidulafungin Susceptibility Testing of Candida glabrata Isolates from Blood Cultures by the MALDI Biotyper Antibiotic (Antifungal) Susceptibility Test Rapid Assay.

Mansoureh Vatanshenassan1,2, Amir Arastehfar2,3, Teun Boekhout2,3, Judith Berman4, Cornelia Lass-Flörl5, Katrin Sparbier6, Markus Kostrzewa6.   

Abstract

Echinocandins are the recommended first-line antifungals for treatment of invasive candidiasis. The increasing number of Candida glabrata strains resistant against echinocandins is an emerging health care concern. The rapid detection of resistant C. glabrata isolates is an urgent requirement for clinical laboratories. In this study, we developed the MALDI Biotyper antibiotic (antifungal) susceptibility test rapid assay (MBT ASTRA) for the rapid detection of anidulafungin-resistant C. glabrata isolates directly from positive blood cultures. Of 100 C. glabrata strains, MBT ASTRA classified 69 as susceptible and 29 as resistant. Microdilution assays performed according to the Clinical and Laboratory Standards Institute (CLSI) guidelines, used as a standard reference, identified 65 susceptible, 9 intermediate, and 26 resistant isolates. Sequencing of hot spot 1 and hot spot 2 regions of the FKS1 and FKS2 genes classified 86 susceptible and 14 resistant isolates. The MBT ASTRA had sensitivity and specificity of 80% and 95%, respectively, compared to the microdilution method. Positive and negative agreement of MBT ASTRA was calculated at 100% and 80%, respectively, compared with the molecular sequencing approach. Together, these results revealed a high accuracy of MBT ASTRA compared to microdilution according to the CLSI and PCR analysis, resulting in a categorical agreement of 90% and 83%, respectively. The validity of MBT ASTRA was 98%. Importantly, MBT ASTRA provided antifungal susceptibility testing (AFST) within 6 h that was both accurate and reliable compared to the other two approaches, which require at least 24 h or are costly. Therefore, this method has the potential to facilitate clinical AFST rapidly at low sample costs for clinical labs already equipped with matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS).
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  C. glabrata; MBT ASTRA; anidulafungin; positive blood samples; rapid antifungal susceptibility testing

Mesh:

Substances:

Year:  2019        PMID: 31285227      PMCID: PMC6709499          DOI: 10.1128/AAC.00554-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

Review 1.  Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.

Authors:  M A Pfaller; D J Diekema; D Andes; M C Arendrup; S D Brown; S R Lockhart; M Motyl; D S Perlin
Journal:  Drug Resist Updat       Date:  2011-02-24       Impact factor: 18.500

2.  In Vitro Exposure to Increasing Micafungin Concentrations Easily Promotes Echinocandin Resistance in Candida glabrata Isolates.

Authors:  María Ángeles Bordallo-Cardona; Pilar Escribano; Elia Gómez G de la Pedrosa; Laura Judith Marcos-Zambrano; Rafael Cantón; Emilio Bouza; Jesús Guinea
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

3.  Yeast identification by sequencing, biochemical kits, MALDI-TOF MS and rep-PCR DNA fingerprinting.

Authors:  Ying Zhao; Chi-Ching Tsang; Meng Xiao; Jasper F W Chan; Susanna K P Lau; Fanrong Kong; Yingchun Xu; Patrick C Y Woo
Journal:  Med Mycol       Date:  2018-10-01       Impact factor: 4.076

4.  Next-generation sequencing offers new insights into the resistance of Candida spp. to echinocandins and azoles.

Authors:  Cécile Garnaud; Françoise Botterel; Natacha Sertour; Marie-Elisabeth Bougnoux; Eric Dannaoui; Sylvie Larrat; Christophe Hennequin; Jesus Guinea; Muriel Cornet; Danièle Maubon
Journal:  J Antimicrob Chemother       Date:  2015-05-27       Impact factor: 5.790

5.  Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013).

Authors:  Mariana Castanheira; Shawn A Messer; Paul R Rhomberg; Michael A Pfaller
Journal:  Diagn Microbiol Infect Dis       Date:  2016-02-09       Impact factor: 2.803

Review 6.  Current status of antifungal resistance and its impact on clinical practice.

Authors:  Laura Alcazar-Fuoli; Emilia Mellado
Journal:  Br J Haematol       Date:  2014-04-18       Impact factor: 6.998

7.  Abdominal candidiasis is a hidden reservoir of echinocandin resistance.

Authors:  Ryan K Shields; M Hong Nguyen; Ellen G Press; Cornelius J Clancy
Journal:  Antimicrob Agents Chemother       Date:  2014-10-06       Impact factor: 5.191

Review 8.  Echinocandin resistance: an emerging clinical problem?

Authors:  Maiken C Arendrup; David S Perlin
Journal:  Curr Opin Infect Dis       Date:  2014-12       Impact factor: 4.915

Review 9.  Invasive candidiasis as a cause of sepsis in the critically ill patient.

Authors:  Julie Delaloye; Thierry Calandra
Journal:  Virulence       Date:  2013-08-27       Impact factor: 5.882

10.  Potential Use of MALDI-ToF Mass Spectrometry for Rapid Detection of Antifungal Resistance in the Human Pathogen Candida glabrata.

Authors:  Antonietta Vella; Elena De Carolis; Enrica Mello; David S Perlin; Dominique Sanglard; Maurizio Sanguinetti; Brunella Posteraro
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

View more
  9 in total

Review 1.  Mass spectrometry in research laboratories and clinical diagnostic: a new era in medical mycology.

Authors:  Hasti Kamali Sarvestani; Alireza Ramandi; Muhammad Ibrahim Getso; Taraneh Razavyoon; Javad Javidnia; Miaad Banay Golrizi; Ali-Akbar Saboor-Yaraghi; Saham Ansari
Journal:  Braz J Microbiol       Date:  2022-03-28       Impact factor: 2.214

2.  Echinocandins Susceptibility Patterns of 2,787 Yeast Isolates: Importance of the Thresholds for the Detection of FKS Mutations.

Authors:  Marie Desnos-Ollivier; Stéphane Bretagne; Olivier Lortholary; Françoise Dromer
Journal:  Antimicrob Agents Chemother       Date:  2022-04-12       Impact factor: 5.938

3.  Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Antimicrobial Susceptibility Testing.

Authors:  Evgeny A Idelevich; Karsten Becker
Journal:  J Clin Microbiol       Date:  2021-06-16       Impact factor: 5.948

Review 4.  Matrix-Assisted Laser Desorption Ionization Time-of-Flight for Fungal Identification.

Authors:  Anna F Lau
Journal:  Clin Lab Med       Date:  2021-04-24       Impact factor: 2.172

Review 5.  Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium.

Authors:  Amir Arastehfar; Toni Gabaldón; Rocio Garcia-Rubio; Jeffrey D Jenks; Martin Hoenigl; Helmut J F Salzer; Macit Ilkit; Cornelia Lass-Flörl; David S Perlin
Journal:  Antibiotics (Basel)       Date:  2020-12-08

Review 6.  Rapid Antifungal Susceptibility Testing of Yeasts and Molds by MALDI-TOF MS: A Systematic Review and Meta-Analysis.

Authors:  Miriam Alisa Knoll; Hanno Ulmer; Cornelia Lass-Flörl
Journal:  J Fungi (Basel)       Date:  2021-01-18

Review 7.  MALDI-TOF MS in a Medical Mycology Laboratory: On Stage and Backstage.

Authors:  Marie-Gladys Robert; Muriel Cornet; Aurélie Hennebique; Tahinamandranto Rasamoelina; Yvan Caspar; Léa Pondérand; Marie Bidart; Harmonie Durand; Marvin Jacquet; Cécile Garnaud; Danièle Maubon
Journal:  Microorganisms       Date:  2021-06-12

8.  Low level of antifungal resistance of Candida glabrata blood isolates in Turkey: Fluconazole minimum inhibitory concentration and FKS mutations can predict therapeutic failure.

Authors:  Amir Arastehfar; Farnaz Daneshnia; Mohammadreza Salehi; Melike Yaşar; Tuğrul Hoşbul; Macit Ilkit; Weihua Pan; Ferry Hagen; Nazlı Arslan; Hatice Türk-Dağı; Süleyha Hilmioğlu-Polat; David S Perlin; Cornelia Lass-Flörl
Journal:  Mycoses       Date:  2020-08-05       Impact factor: 4.377

9.  A rapid MALDI-TOF mass spectrometry-based method for colistin susceptibility testing in Escherichia coli.

Authors:  Jiaping Li; Yonglu Huang; Yanyan Hu; Qiaoling Sun; Jiachang Cai; Hongwei Zhou; Danxia Gu; Gongxiang Chen; Yang Wang; Rong Zhang
Journal:  Microb Biotechnol       Date:  2021-05-20       Impact factor: 5.813

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.